alexa Abstract | Potential of Liposome-incorporated Antimicrobial drugs for treatment in clinically important bacterial strains

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Reviews Open Access


This review focuses on the use of liposomes as a drug delivery agent in clinical bacterial strains. Liposomes were preferentially developed because of their composition, which is compatible with biological constituents and unique physicochemical properties, such as ultra small and controllable size, large surface area, high reactivity and functional structure. These properties facilitate the administration of drugs, thereby overcoming some of the limitations in the traditional antibacterial therapeutics. Numerous antibiotics have been prescribed to kill or inhibit the growth of bacteria. Even though the therapeutic efficacy of these drugs is understood, inefficient delivery could result in inadequate therapeutic index, and local and systemic side effects. Research on liposome technology has progressed from conventional vesicles to 'second-generation liposomes', in which long-circulating liposomes can be obtained by modulating the lipid composition, size and charge of the vesicle. It is clear that encapsulation of antibiotics in liposomes has emerged as an innovative and promising alternative that enhances therapeutic efficacy, minimizes undesirable side effects of the drugs, improves the risk-benefit ratio and prevents emerging drug resistant bacteria. The ability and current state of liposomes for delivering various antibiotics are reviewed here, while exploring the shared interests between nano-engineers and microbiologists in developing nanotechnology for the treatment of infectious diseases.

To read the full article Peer-reviewed Article PDF image

Author(s): Jainamboo M and Praseetha P K


Liposomes, Antibiotic carrier, Drug delivery, antibiotic, infectious diseases, bacteria, Antimicrobial drugs

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version